September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Bilateral Macular Protection Pigment and Lens Density Status in Recently Operated Unilateral Pseudophakic Patients
Author Affiliations & Notes
  • Amy Schnegg
    William E. Sponsel, M.D., San Antonio, Texas, United States
    Rosenberg School of Optometry, University of the Incarnate Word, San Antonio, Texas, United States
  • William Eric Sponsel
    William E. Sponsel, M.D., San Antonio, Texas, United States
    Rosenberg School of Optometry, University of the Incarnate Word, San Antonio, Texas, United States
  • Richard A Bone
    Physics, Florida International University, Miami, Florida, United States
  • Matthew Aaron Reilly
    Biomedical Engineering, University of Texas San Antonio, San Antonio, Texas, United States
  • Shannon Leon
    Rosenberg School of Optometry, University of the Incarnate Word, San Antonio, Texas, United States
  • Sylvia Cervantes
    William E. Sponsel, M.D., San Antonio, Texas, United States
  • Footnotes
    Commercial Relationships   Amy Schnegg, None; William Sponsel, GUARDiON Health Sciences (C); Richard Bone, GUARDiON Health Sciences (C); Matthew Reilly, None; Shannon Leon, None; Sylvia Cervantes, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 3109. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Amy Schnegg, William Eric Sponsel, Richard A Bone, Matthew Aaron Reilly, Shannon Leon, Sylvia Cervantes; Bilateral Macular Protection Pigment and Lens Density Status in Recently Operated Unilateral Pseudophakic Patients. Invest. Ophthalmol. Vis. Sci. 2016;57(12):3109.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To confirm that the perimacular pigment blue light blocking effect is approximately the same whether measured through the natural crystalline lens or the recently placed intraocular lens in paired eyes. Secondarily, to confirm that the Alcon AcrySof SN60WF blue light blocking IOL is effective at blocking blue light as advertised.

Methods : Five patients, 52 years old or greater, all of whom had cataract extraction surgery with implantation of the SN60WF IOL in only one eye within the past year, were measured bilaterally on GUARDiON Health Sciences' MAPCATsf Densometer. The measurements taken on each eye included Macular Pigment Optical Density (MPOD) and Lens Optical Density (LOD). Percent Blue Light Blocking (%BLB) and Lens Equivalent Age (LEA) are also calculated as part of the measurements.

Results : Paired t-test between the paired phakic/pseudophakic eyes of the 5 patients yielded P values greater than 0.72 for each of the four measurements. 100% of the pseudophakic eyes had LEAs of 55 yrs or more. Average IOL LEA of the 5 patients was 75.8.

Conclusions : Measurement of the MPOD and %BLB yielded similar results whether measuring through the patient's natural crystalline lens or through the recently placed PCIOL. The LOD and LEA measured between the paired eyes also yielded similar results, demonstrating the blue light blocking characteristics of the Alcon AcrySof SN60WF to be comparable to the patient's natural crystalline lens, consistent with the implant’s commercial representation.

Nolan et. al used hetrochromatic flicker photometry (also used by MAPCATsf) to measure MPOD before and after cataract surgery and found there was no statistical difference in MPOD measurement of the patient through cataract opacity and blue-light blocking IOLs.

Our study confirms that MPOD can be measured through a natural crystalline lens or through a recently implanted SN60WF IOL and yield comparable results. Also confirmed is Alcon's claim of the SN60WF's blue-light blocking capabilities. These findings help support a larger scale study to determine whether blue-light blocking levels are diminished with older model non-blue-blocking IOLs in relation to the fellow phakic eye. With these preliminary assurances, we now intend to study whether MPOD decreases in the unilateral pseudophakic eye with non-blue-light blocking IOL over varying time periods versus the fellow eye that has remained phakic.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×